US Supplement Firms Warned About Offering Menu Of Disease Treatments, Topped By Diabetes
Three weeks after warning 10 firms, FDA publishes warnings identifying diabetes claims firms in New York and Tennessee; in August, it found so many violative claims by firms in Idaho and Oregon it might have been more efficient to identify diseases their products weren’t promoted to treat.
You may also be interested in...
Decision, explained by Principal Deputy Commissioner Woodcock, turns page on FDA’s 2019 announcement, after hemp was de-scheduled in 2018 farm bill, it would consider rulemaking for lawful use of hemp in supplements.
Former acting commissioner Stephen Ostroff and Sharon Lindan Mayl, previously a senior advisor to FDA commissioner on food programs, say Reagan-Udall report was accurate in finding that establishing food program leadership with defined authorities is key to improving the programs, which include regulation of supplement manufacturing and marketing.
“Right now, it looks like [FDA’s] hands are tied because that's their message … But they're holding both ends of the rope. Come on, get that knot undone,” says AHPA president Michael McGuffin. “To anybody who's looking at this as an outsider, you would say, ‘What is the agency doing?’’ says NPA CEO Daniel Fabricant.